ICON is a contract research organization (CRO) which provides outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries. These solutions span the clinical development lifecycle from compound selection to Phase I-III clinical studies and post approval outcome research and market access consulting solutions. ICON’s services assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster and the company has the expertise and capability to conduct clinical trials in most major therapeutic areas either on a stand-alone basis or as part of an integrated “full service” solution. ICON employs approximately 15,000 employees from 99 locations in 40 countries.